Ribophorin II Overexpression Is Associated with Poor Response to Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in P16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma

Ribophorin II Overexpression Is Associated with Poor Response to Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in P16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma

This study aims to evaluate the relationship between human ribophorin II (<i>RPN2</i>) and the effect of treatment using induction therapy with docetaxel, cisplatin, and fluorouracil (TPF) for <i>p</i>-16 negative locally advanced head and neck squamous cell carcinoma (HNSCC)...

Full description

Bibliographic Details
Main Authors: Wei-Shan Chen, Sheng-Dean Luo, Tai-Jan Chiu, Yu-Ming Wang, Wei-Chih Chen, Chih-Yen Chien, Fu-Min Fang, Tai-Lin Huang, Shau-Hsuan Li
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Journal of Clinical Medicine
Subjects:
head and neck cancer
ribophorin II (RPN2)
induction chemotherapy
Online Access:https://www.mdpi.com/2077-0383/10/18/4118

Internet

https://www.mdpi.com/2077-0383/10/18/4118

Similar Items